Abstract
BackgroundThe recruitment of clinical trial participants in a timely manner is one of the greatest obstacles to developing the next Huntington’s disease (HD) treatment. In the past, if individuals were...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have